— Know what they know.
Not Investment Advice

ZBIO NASDAQ

Zenas BioPharma, Inc.
1W: +5.0% 1M: -1.1% 3M: -23.3% YTD: -42.5% 1Y: +72.8%
$18.97
-0.87 (-4.39%)
 
Weekly Expected Move ±11.6%
$14 $16 $18 $20 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 49 · $846.9M mcap · 10M float · 6.72% daily turnover · Short 54% of daily vol
Last Earnings 2026-03-16
EPS
$-1.10
▼ Miss -9.8%
Revenue
$13M
Est (actual pending)
Next Earnings 2026-08-18
EPS Estimate
$-1.12
Range: $-1.74 - $-0.16
Revenue Estimate
$15M
2 analysts

Estimate vs Actual

Earnings Surprise History

2/13
EPS Beats
1/13
Revenue Beats
15%
EPS Beat Rate
8%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-18 quarter 2026-09-30 $-1.25 $-1.28 ▼ 0.03 $— $—
2026-05-18 annual 2028-12-31 $-4.05 $-4.15 ▼ 0.10 $146,892,844 $146,892,844
2026-05-18 annual 2026-12-31 $-4.71 $-4.81 ▼ 0.10 $21,883,333 $21,883,333
2026-05-18 annual 2029-12-31 $-2.48 $-2.62 ▼ 0.14 $308,522,750 $308,522,750
2026-05-18 annual 2027-12-31 $-4.63 $-4.73 ▼ 0.10 $50,749,504 $50,749,504
2026-05-18 quarter 2026-06-30 $-1.10 $-1.12 ▼ 0.02 $15,000,000 $15,000,000
2026-05-18 quarter 2026-12-31 $-0.91 $-0.93 ▼ 0.02 $11,260,000 $11,260,000
2026-05-18 annual 2030-12-31 $-0.62 $-0.73 ▼ 0.11 $509,908,000 $509,908,000
2026-05-15 quarter 2026-09-30 $-1.27 $-1.25 ▲ 0.02 $— $—
2026-05-15 annual 2026-12-31 $-4.93 $-4.71 ▲ 0.22 $9,383,333 $21,883,333
2026-05-15 quarter 2027-12-31 $-1.41 $-1.00 ▲ 0.41 $5,300,000 $5,300,000
2026-05-15 quarter 2027-03-31 $-1.45 $-1.14 ▲ 0.31 $1,592,200 $1,592,200
2026-05-15 annual 2029-12-31 $-2.69 $-2.48 ▲ 0.22 $308,522,750 $308,522,750
2026-05-15 annual 2028-12-31 $-4.08 $-4.05 ▲ 0.03 $130,226,178 $146,892,844
2026-05-15 quarter 2027-09-30 $-1.39 $-1.02 ▲ 0.37 $1,600,000 $1,600,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms